oral semaglutide news Lilly's GLP-1 pill seen as superior in head-to-head trial with Novo's FDA accepts filing application for

Moreira PI, Santos MS, Moreno AM, Seia R, Oliveira CR

Improvement and competition is expected over time, whether by creating more modifications to improve half-life , improving access to the brain, converting existing injectable drugs into oral forms, combining with other agonists or antagonists (Molecules that prevent receptors/molecules from functioning) such as DPP-4 inhibitors, which help extend the half-life of peptides such as GLP-1 and GIP

While originally intended as a diabetes medication, they also have proven to be effective for weight loss, with patients losing on average 10 to 20 percent of their body weight

With proper management, the long-term benefits of this treatment outweigh the temporary discomforts

Saffron extract has been studied for its role in reducing emotional or compulsive eating